Build a Smart Anti-Pollution Mask With a Connected Nebulizer

1. 1

   Recognize this is a regulated combination device, not a gadget

   The defining fact is that auto-dispensing prescribed respiratory medication makes this a drug-delivery device, likely an FDA combination product, subject to far heavier regulation than a passive filtration mask. Team Caeli's 2019 Imagine Cup prototype showed the concept; commercializing it is a medical-device undertaking. Distinguish this from the passive AI smart pollution mask card in this file: adding automated medication delivery is what raises the regulatory and clinical bar dramatically. Plan accordingly from day one.

2. 2

   Prove the clinical concept and safety of automated dispensing

   Automatically delivering medication based on an environmental trigger raises real clinical questions: correct dosing, avoiding over-delivery, patient-specific prescriptions, and fail-safes. Work with pulmonologists to define when and how much medication is appropriate, and design conservative, safe automation with human oversight. The clinical safety case is the heart of the product, and getting it wrong is dangerous, not just non-compliant.

3. 3

   Engineer the sensor, nebulizer, and mask as an integrated device

   Integrate an AQI sensor, a connected nebulizer capable of accurate metered dosing, filtration, and connectivity into a wearable, which is a serious drug-delivery and hardware engineering challenge. Metered-dose accuracy and reliability are regulated and safety-critical. Prototype the drug-delivery mechanism early and validate dosing precision, because this is where the device is hardest and most consequential.

4. 4

   Plan the FDA combination-product regulatory pathway

   A device that delivers a drug based on AI-driven triggers touches device and drug regulation together. Engage regulatory strategy early to map the combination-product pathway, the clinical evidence required, and the AI change-control expectations. This is a multi-year, capital-heavy path, which is exactly why time to first dollar is measured in years and viability is honestly modest. Do not build consumer features before the regulatory concept is sound.

5. 5

   Add the least-polluted-route navigation as a supporting feature

   Intelligent least-polluted-route navigation (guiding a user through cleaner air) is a valuable app-layer feature and a lower-regulatory-risk complement to the dispensing device. It strengthens the value proposition for respiratory patients and can even ship earlier as a standalone app to build an audience and validate demand while the regulated device works through its long pathway. Use it to de-risk, but do not mistake it for the core device.

Do not take our word for the money. Put your own numbers in and see what this idea has to earn before it works. Free, instant, no account needed.

Best for: Well-funded medical-device teams with drug-delivery and regulatory expertise, not consumer-hardware generalists

Not for: Not for anyone unprepared for combination-device regulation and clinical validation; that path defines the project. Not for founders without qualified regulatory, clinical, and pharmacy expertise. This is a regulated medical-device space (FDA clearance and quality-system requirements), so confirm the regulatory pathway with qualified experts and treat nothing here as regulatory, clinical, or medical advice.